This is an HTML version of an attachment to the Freedom of Information request 'Advisory Panel on COVID-19 Vaccines – Register of Members’ Interests'.

Annex 
Advisory Panel on COVID-19 Vaccines 
Summary of Declaration of Interests by Members 
(Position as at 27 August 2021) 
 
Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
Convenor   
Professor LAU 
Nil 
1. Chair and Daniel CK Yu 
Nil 
Nil 
Chak-sing, Wallace, 
Professor, Division of 
JP 
Rheumatology and Clinical 
 
Immunology, Department of 
Medicine, HKU 
2. Head, Department of 
Medicine, HKU 
3. Chief of Service, Department 
of Medicine, Queen Mary 
Hospital 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
Member  Dr AU YEUNG 
1. Council member of 
1. Consultant, the Hong Kong 
Nil 
Nil 
Tung-wai 
The Hong Kong 
Hospital Authority 
 
Geriatrics Society 
2. Part-time lecturer, CUHK 
2. Council member of 
The Chinese 
Dementia Research 
Association 
3. Council member of 
The Hong Kong 
Specialist Medical 
Association 
4. Editor-in-chief of 
Asian Journal of 
Gerontology and 
Geriatrics 
 
The above organisations 
will and have received 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
sponsorships for the 
purpose of continuous 
medical education from 
various pharmaceutical 
companies including 
Pfizer and AstraZeneca. 
 
Member  Professor Keiji 
Nil 
Director, School of Public 
Nil 
Nil 
FUKUDA   
Health, Li Ka Shing Faculty of 
 
Medicine, HKU 
 
Member  Professor LAU Yu- 1. Founder and 
Chair Professor, Department of  Nil 
Principal Investigators for 
lung, JP   
Committee Member,  Paediatrics & Adolescent 
multiple industry-
 
Children’s 
Medicine, HKU 
sponsored vaccine trials 
Catastrophic Disease 
over many years mainly 
Foundation 
with GSK.    As Founding 
2. Executive Committee 
President of Asia Pacific 
Member, Society for 
Society for 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
the Relief of Disabled 
Immunodeficiencies, 
Children 
sponsorship from various 
3. Founder and Board of 
pharmaceutical companies, 
Governors Member, 
in particular CSL Behring, 
Children's 
have been received. 
Thalassaemia 
Foundation 
4. Founding President, 
Asia Pacific Society 
for 
Immunodeficiencies 
 
Member  Dr HO King-man 
Serve in the Council of  Ad hoc teaching in courses 
Nil 
Currently serves in the 
 
the HK College of 
organized by HKU, PolyU, 
Councils of the following 
Dermatologists, HK 
CUHK 
professional associations: 
Society for Paediatric 
1.  HK Society for 
Dermatology, 
Paediatric Dermatology 
Association for 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
Integrated Aesthetic 
(non-profit making 
Medicine, and Asia 
organization) 
Dermatological 
2.  HK College of 
Association 
Dermatologists (non-
 
profit making 
The above organisations 
organization) 
might have received 
3.  Asian Dermatological 
sponsorships from 
Association (non-profit 
various pharmaceutical 
making organization) 
companies including 
4.  Association for 
Pfizer (but never 
Integrative Aesthetic 
SinoVac) in educational 
Medicine, HK (in the 
events or activities.   
process of application 
Dr HO have not 
for non-profit making 
received any 
organization) 
remuneration from these 
 
services in these 
These professional 
Society/Associations. 
associations may organize 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
educational activities for 
local doctors or healthcare 
professionals and the 
industry may sponsor 
overseas or local speakers 
to deliver lectures or set up 
exhibition booth in these 
activities.    As far as 
Dr HO knows, Pfizer, 
Astrazeneca, BioNtech, 
and Sinovac seldom, if 
any, sponsor or set up 
booth in educational 
activities organized by 
these associations. 
 
Dr HO has not received 
any remuneration by 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
serving in the Councils of 
these professional 
associations.    Asian 
Dermatological 
Association will sponsor 
one night hotel 
accommodation for him to 
attend the Annual General 
Meeting should it be 
organised in cities outside 
Hong Kong.    The 
sponsorship is derived 
from the internal resource 
of the Association. 
 
Member  Professor HUI Shu- Nil 
An advisor to Roche on clinical  Nil 
Chairperson of the 
cheong, David, 
research related to Baloxavir for 
organising committee for 
treatment of influenza 
the “CUHK Advances in 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
BBS 
Medicine annual 
 
conference” and 
organising committee for 
the “Hong Kong Thoracic 
Society annual scientific 
meeting and autumn 
respiratory seminar” 
 
Member  Professor HUNG 
Nil 
Nil 
Nil 
Received honoraria as 
Fan-ngai, Ivan   
Advisory Board Member 
 
for Pfizer, Roche, 
AstraZeneca, MSD, 
Abbvie, Ferring, Gilead 
and Chong Lap 
 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
Member  Professor Gabriel 
Nil 
Dean of the Faculty of Medicine  Nil 
1.  Serve on the Health 
Matthew LEUNG, 
of HKU which has one COVID-
Committee of the Belt 
GBS, JP   
19 vaccine under development 
and Road General 
 
Chamber of Commerce, 
in which one of the 
committee members is 
the Executive Director 
of Sino 
Biopharmaceutical 
Limited, a listed 
company in Hong Kong 
which had bought a 
significant stake in 
Sinovac Biotech 
Limited (Sinovac) 
2.  According to 
Prof LEUNG’s 
understanding, 

 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
BioNTech vaccine has 
no relation with Pfizer 
Corporation Hong 
Kong Limited (“Pfizer 
Hong Kong”). 
However, he would like 
to declare that he has a 
professional 
acquaintance with the 
Country Manager of 
Pfizer Hong Kong for a 
long time 
Member  Professor LIANG 
1. Hong Kong Medical 
Hong Kong Sanatorium & 
Nil 
Nil 
Hin-suen, 
Museum 
Hospital (HKSH Medical Group) 
Raymond, SBS, JP   2. Hong Kong Marrow 
 
Match Foundation 
3. Hong Kong Blood 
Cancer Foundation 
10 
 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
4. Hong Kong Academy 
of Medicine 
Foundation Fund 
Member  Dr TSANG Ho-fai,  Nil 
Nil 
Nil 
Pfizer is one of the 
Thomas 
sponsors for Annual 
 
Scientific Meetings of the 
Hong Kong College of 
Community Medicine of 
which Dr TSANG is the 
current President. 
 
Member  Professor WONG 
1. Independent non-
1. Lo Shiu Kwan Kan Po Ling 
Therakind Limited  1.  Lead Scientist in 
Chi-kei, Ian 
executive director of 
Endowed Professor in 
(UK) 
Research Programme 4. 
 
Jacobson (Hong 
Pharmacy and Head of 
Laboratory of Data 
Kong) since 2017 
Department of Pharmacology 
Discovery for Health 
2. Director of Healthcare 
& Pharmacy, HKU 
Limited (D24H). 
Innovation 
2. Chair Professor of Pharmacy 
InnoHK since 
Practice and Medicine 
November 2020 
11 
 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
Technology Service 
Evaluation Research, 
2.  Member of Independent 
(London) since 2007 
University College London 
Scientific Advisory 
(UCL) School of Pharmacy, 
Committee (ISAC) for 
London 
Clinical Practice 
Research Datalink 
(CPRD) of UK 
Medicines and 
Healthcare Products 
Regulatory Agency 
(2016-2021) 
3.  Co-Director of Centre 
for Medication 
Optimisation Research 
and Education at the 
University College 
London Hospital (Since 
2016) 
12 
 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
4.  Specialist Advisor to 
NPS Medicinewise in 
Australia on 
MedicineInsight (since 
2018) 
5.  Member of Hong Kong 
Pharmacy and Poisons 
Board (Regulatory 
Authority in Hong 
Kong) (since 2018) 
6.  Consultant to IQVIA 
(since 2018) 
7.  Principal investigator of 
“COVID-19 Vaccines 
Adverse Events 
Response and 
Evaluation (CARE) 
Programme” funded by 
13 
 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
the Food and Health 
Bureau 
 
Member  Professor YUEN 
1. Managing Director of  1. Clinical Professor (Chair of 
Nil 
1.  Collaborations with the 
Kwok-yung, GBS, 
Centre for Virology, 
Infectious Diseases), 
Wantai pharmaceutical/ 
JP 
Vaccinology and 
Department of Microbiology, 
Xiamen University and 
 
Therapeutics Limited 
HKU 
the Changchun Bai Kai, 
2. Director of The Hong  2. Service Director (Path), Hong 
BCHT (長春百克) 
Kong Academy of 
Kong West Cluster, Hospital 
pharmaceutical in the 
Sciences 
Authority 
phase 1 clinical trial for 
the HKU intranasal 
Covid-19 vaccine 
2.  Collaboration with the 
company that 
manufactures the 
14 
 

Panel 
Name 
Proprietorships, 
Remunerated employments, 
Shareholdings in 
Other declarable 
partnerships or 
offices, trades, professions or  companies, public 
interests 
directorships of 
vacations 
or private (1% or 
companies, public or 
more of the 
private 
company’s issued 
share capital) 
intramuscular ICCOV 
DNA vaccine:  广州白
云山拜迪生物医药有
限公司  Guangzhou 
Baiyunshan Baidi 
Biotechnology Co., Ltd 
 
 
15